atopic dermatitis Archives

source: shutterstock.com

Dupixent Label Update Reflects Safety and Efficacy Results for Moderate-to-Severe Atopic Dermatitis with Severe Hand/Foot Involvement

Post author:Jessica Lynn
Post published:February 7, 2024
Post category:Atopic dermatitis

According to reporting from Healio Psoriatic Disease, the Food and Drug Administration (FDA) recently updated the label for Dupixent (dupilumab) in the indication of moderate-to-severe atopic dermatitis with moderate-to-severe hand…

source: pixabay.com

Methotrexate or Cyclosporin: Which is More Effective for Pediatric Atopic Dermatitis?

Post author:Jessica Lynn
Post published:October 25, 2023
Post category:Atopic dermatitis

Both methotrexate and cyclosporin may be leveraged to treat severe atopic dermatitis in children. But is one treatment more effective than the other? Researchers attempted to answer this question…

Source: www.pixabay.com

Nemolizumab Reduces Pruritus (Itchiness) in Children with Atopic Dermatitis

Post author:Jessica Lynn
Post published:August 19, 2023
Post category:Atopic dermatitis

An estimated 25% of children globally are affected by atopic dermatitis; you may known this skin condition by its more colloquial name, "eczema." Often manifesting by five years old, atopic…

source: pixabay.com

Study of the Week: Severe Atopic Dermatitis May Increase Non-Hodgkin Lymphoma Risk

Post author:James Moore
Post published:June 20, 2022
Post category:Atopic dermatitis Non-Hodgkin lymphoma Non-Hodgkin's Lymphoma Severe Atopic Dermatitis

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

StockSnap / Pixabay

Bleach Baths May Improve Severe Atopic Dermatitis Symptoms

Post author:Jessica Lynn
Post published:June 17, 2022
Post category:Severe Atopic Dermatitis

In the past, research has shown that bleach baths can be a helpful tool in addressing or relieving symptoms associated with dermatological issues. For example, some doctors suggest the use…

https://unsplash.com/photos/tWTFjznQlBA

SHR0302 Helps Clear Severe AD, Study Says

Post author:Jessica Lynn
Post published:May 12, 2021
Post category:Severe Atopic Dermatitis

According to MedPage Today, data from a preliminary study evaluating SHR0302, an investigational Janus kinase 1 (JAK1) inhibitor, showed promise for treating patients with moderate-to-severe atopic dermatitis (AD). Following treatment,…

Source: pixabay.com

Severe Pediatric Atopic Dermatitis Linked to Learning Disabilities

Post author:Jessica Lynn
Post published:April 20, 2021
Post category:Severe Atopic Dermatitis

According to HCP Live, a new study may have discovered a connection between severe pediatric atopic dermatitis and learning disabilities. Researchers, spearheaded by Dr. Joy Wan, MD, MSCE from the…

DUPIXENT Approved in Canada for Pediatric Atopic Dermatitis

Post author:Jessica Lynn
Post published:March 5, 2021
Post category:Severe Atopic Dermatitis

For patients with severe atopic dermatitis, it can be difficult to find adequate treatment options. For many, treatment revolves around topical creams, anti-inflammatory medications, light therapy, antibiotics, and more. But…

chezbeate / Pixabay

KHK4083 Shows Promise for Severe Atopic Dermatitis

Post author:Jessica Lynn
Post published:March 1, 2021
Post category:Severe Atopic Dermatitis

On February 18, 2021, specialty pharmaceutical company Kyowa Kirin Co., Ltd. ("Kyowa Kirin") shared that a Phase 2 clinical trial evaluating KHK4083 had reached its primary endpoint. KHK4083 is an…

Source: pixabay.com

Thykamine for Atopic Dermatitis Met Primary Trial Endpoint

Post author:Jessica Lynn
Post published:February 25, 2021
Post category:Severe Atopic Dermatitis

Recently, botanical pharmaceutical company Devonian Health Group Inc. ("Devonian") has been evaluating its product thykamine for patients with mild-to-moderate atopic dermatitis in a Phase 2 clinical trial. In a…

Deedee86 / Pixabay

Patients to Be Recruited Into ASLAN004 Expansion Cohort for Atopic Dermatitis

Post author:Jessica Lynn
Post published:January 18, 2021
Post category:Severe Atopic Dermatitis

In a recent press release, biopharmaceutical company ASLAN Pharmaceuticals ("ASLAN") announced that it would begin recruiting patients for an expansion cohort of a clinical trial evaluating ASLAN004 for patients…

source: pixabay.com

A New Phase 3 Trial is Being Initiated to Evaluate Etrasimod for Atopic Dermatitis

Post author:Jessica Lynn
Post published:November 12, 2020
Post category:Severe Atopic Dermatitis

After announcing positive results from a Phase 2b ADVISE trial, Arena Pharmaceuticals, Inc. ("Arena") hopes to soon initiate a Phase 3 clinical trial to evaluate etrasimod as a treatment…

Positive Results of Phase 2 Trial for Atopic Dermatitis Announced

Post author:Trudy Horsting
Post published:November 4, 2020
Post category:Severe Atopic Dermatitis

Positive results have just been announced for a Phase 2 study called QUARTZ2, investigating SHR0302 as a therapy for atopic dermatitis (AD). Researchers found that at every dose level examined,…

pixabay.com

EMA Recommends Olumiant for Severe Atopic Dermatitis

Post author:Jessica Lynn
Post published:September 28, 2020
Post category:Atopic dermatitis

Recently, the European Medicines Agency (EMA) recommended Olumiant (baricitinib) for the treatment of adult patients with moderate to severe atopic dermatitis. Currently, Olumiant is approved for the treatment of…

geralt / Pixabay

Ring in the New Year with New Atopic Dermatitis Treatments

Post author:Minden Cantrell
Post published:December 11, 2017
Post category:Rare Disease Severe Atopic Dermatitis

For people suffering from severe atopic dermatitis (AD), commonly referred to as severe eczema, relief may be in sight, according to a recent article in Dermatology Times. If you're one of…

https://pixabay.com/en/globe-earth-world-globalization-895580/

Severe Atopic Dermatitis May Be Less Rare Than We Realize

Post author:Trudy Horsting
Post published:June 30, 2017
Post category:Rare Disease Severe Atopic Dermatitis

Contagion Live (Infectious Diseases Today) recently discussed a journal article on the prevalence of atopic dermatitis. The simple summary? More research is needed to uncover just how common this condition is. BUT…

https://pixabay.com/en/stones-rocks-pebbles-tranquil-zen-167089/

This Man is Drawing Inspiration from His Atopic Dermatitis Experience

Post author:Trudy Horsting
Post published:June 29, 2017
Post category:Rare Disease Severe Atopic Dermatitis

It’s amazing how much we take for granted. Eating. Seeing. Walking. There are a million and one things that can go wrong with the human body, and until one of…

Dupixent Label Update Reflects Safety and Efficacy Results for Moderate-to-Severe Atopic Dermatitis with Severe Hand/Foot Involvement

Methotrexate or Cyclosporin: Which is More Effective for Pediatric Atopic Dermatitis?

Nemolizumab Reduces Pruritus (Itchiness) in Children with Atopic Dermatitis

Study of the Week: Severe Atopic Dermatitis May Increase Non-Hodgkin Lymphoma Risk

Bleach Baths May Improve Severe Atopic Dermatitis Symptoms

SHR0302 Helps Clear Severe AD, Study Says

Severe Pediatric Atopic Dermatitis Linked to Learning Disabilities

DUPIXENT Approved in Canada for Pediatric Atopic Dermatitis

KHK4083 Shows Promise for Severe Atopic Dermatitis

Thykamine for Atopic Dermatitis Met Primary Trial Endpoint

Patients to Be Recruited Into ASLAN004 Expansion Cohort for Atopic Dermatitis

A New Phase 3 Trial is Being Initiated to Evaluate Etrasimod for Atopic Dermatitis

Positive Results of Phase 2 Trial for Atopic Dermatitis Announced

EMA Recommends Olumiant for Severe Atopic Dermatitis

Ring in the New Year with New Atopic Dermatitis Treatments

Severe Atopic Dermatitis May Be Less Rare Than We Realize

This Man is Drawing Inspiration from His Atopic Dermatitis Experience

The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

“Shades of Psoriasis”: Plaque Psoriasis and Sharing Your Story

Understanding RSV: Why Combatting Ethnic and Age-Related Health Disparities Could Improve Outcomes

We Need Equity and Diversity Within Rare Disease Research

DNA in Color: How Ronya Nelson is Working to Close the Diversity Gap in Genetics - Part 1

Bridging the Diversity Gap in Healthcare

Congratulations to the 2023 Recipients of the Diversity in Lupus Research Awards!

Welcome to Study of the Week. We go in-depth and select a study we think is of particular interest, discussing details, explaining its importance, who may be impacted and lots more!

Let’s Work Together!

Keep Up to Date

Learn More